Cognition Therapeutics Inc CGTX Q1 2026 Earnings Narrower Loss on Lower Expenses No Revenue Reported XXII Q1 2026 Earnings Massive EPS Miss Amid Continued Transition PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 as Core Growth Momentum Continues GENB Q1 2026 Earnings Wider Loss Stings but Pipeline Progress Lifts Shares Werewolf Therapeutics HOWL Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline NWE Q1 2026 Earnings EPS Beats Estimates by 69 Amid Solid Operational Performance